Intranasal formulation of rotigotine

Details Intranasal formulation of rotigotine Intranasal formulation of rotigotine

A - Human Necessities

61

K

A61K 31/381 (2006.01)

Patent

CA 2516400

This invention pertains to a liquid intranasal pharmaceutical formulation comprising a pharmaceutically acceptable acid addition salt of rotigotine and .alpha.-cyclodextrin, preferably in the form of a buffered aqueous solution having a viscosity of 0.5 - 1.5 mm2/s

L'invention porte sur une formulation pharmaceutique intranasale liquide comprenant un sel d'addition acide pharmaceutiquement acceptable de rotigotine et d'.alpha.-cyclodextrine, de préférence sous la forme d'une solution aqueuse tamponnée possédant une viscosité de 0,5 à 1,5 mm?2¿/s.

Affiliated with

Also associated with

Rating

Intranasal formulation of rotigotine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intranasal formulation of rotigotine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasal formulation of rotigotine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1897361